Explore
← New search
Filters:
Cytokine
✕
immunofluorescence microscopy
✕
b16-ova tumor sections, day 12 post-act
✕
clear all
1 matching publication(s)
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8+ T cells.
PMID 37081150 · Nat Immunol · 2023
L1
37/100